Neuromuscular complications in the intensive care unit: Critical illness polyneuromyopathy

AACN Advanced Critical Care

Volumn 18, Issue 2, 2007, Pages 167-182

  Johnson, Karen L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

Author keywords

Critical illness myopathy; Critical illness neuropathy; Critical illness polyneuromyopathy

Indexed keywords

MUSCLE RELAXANT AGENT;

ANAMNESIS; ARTIFICIAL VENTILATION; BIOPSY; CRITICAL ILLNESS; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ELECTRODIAGNOSIS; HUMAN; INCIDENCE; INTENSIVE CARE; METHODOLOGY; MOBILIZATION; MORTALITY; NURSE ATTITUDE; NURSING ASSESSMENT; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; POLYNEUROPATHY; PRIMARY PREVENTION; QUALITY OF LIFE; REVIEW; RISK FACTOR;

BIOPSY; CRITICAL CARE; CRITICAL ILLNESS; DIAGNOSIS, DIFFERENTIAL; EARLY AMBULATION; EARLY DIAGNOSIS; ELECTRODIAGNOSIS; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MEDICAL HISTORY TAKING; NEUROMUSCULAR AGENTS; NURSE'S ROLE; NURSING ASSESSMENT; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICAL EXAMINATION; POLYNEUROPATHIES; PRIMARY PREVENTION; QUALITY OF LIFE; RISK FACTORS; VENTILATOR WEANING;

EID: 34250616327     PISSN: 15597768     EISSN: 15597768     Source Type: Journal    
DOI: 10.4037/15597768-2007-2009     Document Type: Review

References (87)

1. Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and acute respiratory distress syndrome. N Engl J Med. 2000;342:1301-1308.
2. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342:1471-1477.
3. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
4. Van den Berghe F, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
5. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862-871.
6. Collard HR, Saint S, Matthay MA. Prevention of ventilator associated pneumonia: an evidence-based systematic review. Ann Intern Med. 2003;138:494-501.
7. Aichenbaum SR, Ring H. Rehabilitation of a patient with critical illness polyneuropathy following acute respiratory failure: a case report and review of literature. Disabil Rehabil. 2003;25:273-276.
8. Hund E. Myopathy in critically ill patients. Crit Care Med. 1999;27:2544-2547.
9. Bolton CF, Gilbert JJ, Hahn AF, et al. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 1984;47:1223-1231.
10. Benarik J, Lukas Z, Vondracek P. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med. 2003;29:1505-1514.
11. Bednarik J, Vondracek P, Dusek L, Moravcova E, Cundrle I. Risk factors for critical illness polyneuromyopathy. J Neurol. 2005;252:343-351.
12. Leijten FSS, De Weerd AW. Critical illness polyneuropathy: a review of the literature, definition, and pathophysiology. Clin Neurol Neurosurg. 1994;96:10-19.
13. Coakley JH, Nagendran K, Yarwood GD, Honavar M, Hinds CJ. Patterns of neurophysiological abnormality in prolonged critical illness. Intensive Care Med. 1998;24:801-807.
14. De Letter MACJ, Schmitz PIM, Visser LH, et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med. 2001;29:2281-2286.
15. DeJonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288:2859-2867.
16. Bolton CF. Evidence of neuromuscular dysfunction in the early stages of the systemic inflammatory response syndrome. Intensive Care Med. 2000;26:1179-1180.
17. Bercker S, Weber-Carstens S, Deja M, et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med. 2005;33:711-715.
18. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med. 2001;27:1288-1296.
19. Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit stay: the contribution of mechanical ventilation. Crit Care Med. 2005;33:1266-1271.
20. Campellone JV, Lacomis D, Kramer DJ, et al. Acute myopathy after liver transplantation. Neurology. 1998;50:46-53.
21. Friedrich O, Fink RHA, Hund E. Understanding critical illness myopathy: approaching the pathomechanism. J Nutr. 2005;135:1813S-1817S.
22. Suter P, Armaganidis A, Beaufils F, et al. Consensus conference organized by the ESICM and the SRLF: predicting outcome in ICU patients. Intensive Care Med. 1994;10:390-397.
23. Berek K, Margreiter J, Willeit J, et al. Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med. 1996;22:849-855.
24. Zochodne DW, Bolton CF, Wells GA, et al. Critical illness polyneuropathy. Brain. 1987;110:819-842.
25. Hund ER, Fogel W, Krieger D, et al. Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med. 1996;24:1328-1333.
26. de Seze M, Petit H, Wiart L, et al. Critical illness polyneuropathy: a 2-year follow-up in 19 severe cases. Eur Neurol. 2000;43:61-69.
27. Zifko UA. Long-term outcome of critical illness polyneuropathy. Muscle Nerve. 2000;9(suppl):S49-S52.
28. Fletcher SN, Kennedy DD, Ghosh IR, et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med. 2003;31:1012-1016.
29. Dhand UK. Clinical approach to the weak patient in the intensive care unit. Respir Care. 2006;51:1024-1041.
30. Pandit L, Agrawal A. Neuromuscular disorders in critical illness. Clin Neurol Neurosurg. 2006;108:621-627.
31. Lacomis D. Critical illness myopathy. Curr Rheumatol Rep. 2002;4:403-408.
32. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med. 1996;24:1408-1416.
33. Watling SM, Dasta JF. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literature. Crit Care Med. 1994;22:884-893.
34. Zochodne DW. Neuropathies associated with renal failure, hepatic disorders, chronic respiratory disease and critical illness. In: Dyck PJ, Thomas PK, eds. Peripheral Neuropathy. 4th ed. Philadelphia: Elsevier; 2005:2017-2038.
35. Kleyweg R, VanDerMeche F, Schmitz P. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991;164:307-314.
36. Tennila A, Salmi T, Pettila V, et al. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med. 2000;26:1360-1363.
37. Bird S, Rich MM. Critical illness myopathy and polyneuropathy. Curr Neurol Neurosci Rep. 2002;2:527-533.
38. Hund E. Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol. 2001;248:929-934.
39. Trojaborg W, Weimer LH, Hays AP. Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy: a reappraisal. Clin Neurophysiol. 2001;112:1586-1593.
40. Zochodne DW, Bolton CF, Gilbert JJ. Polyneuropathy in critical illness: pathologic features. Ann Neurol. 1985;18:160-166.
41. Faragher MW, Day BJ, Dennett X. Critical care myopathy: an electrophysiological and histological study. Muscle Nerve. 1996;19:516-518.
42. Terman A, Brunk UT. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. FEBS J. 2002;269:1996-2002.
43. Tepper M, Rakic S, Hass JA, et al. Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth J Med. 2000;56:211-214.
44. Lanone S, Taille C, Boczkowski J, Aubier M. Diaphragmatic fatigue during sepsis and septic shock. Intensive Care Med. 2005;31:1611-1617.
45. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31:359-366.
46. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest. 2004;114:1187-1195.
47. Massa R, Carpenter S, Holland P, et al. Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve. 1992;15:1290-1298.
48. Rouleau G, Karpati G, Carpenter S, et al. Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers. Muscle Nerve. 1987;10:428-438.
49. Rich MM, Pinter MJ. Crucial role of sodium channel fast inactivation in muscle fiber inexcitability in a rat model of critical illness myopathy. J Physiol. 2003;547:555-566.
50. v1.5 in a rat model of critical illness myopathy. J Physiol. 2004;559:813-820.
51. DuBois DC, Almon RR. A possible role for glucocorticoids in denervation atrophy. Muscle Nerve. 1981;4:370-373.
52. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348:683-693.
53. Latronico N, Fenzi F. Critical illness myopathy and neuropathy. Lancet. 1996;347:1579-1583.
54. Segredo V, Caldwell JE, Matthay MA, et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med. 1992;327: 524-528.
55. Op De Coul AAW, Lambregts PCLA, Koeman J, et al. Neuromuscular complications in patients given pavulon during artificial ventilation. Clin Neurol Neurosurg. 1985;87:17-22.
56. Griffen D, Fairman N, Coursin D, et al. Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest. 1992;102:510-514.
57. Waldhausen E, Mingers B, Lippers P, Keser G. Critical illness polyneuropathy due to parenteral nutrition. Intensive Care Med. 1997;23:922-923.
58. Marino PL, Millili JJ. Possible role of dietary lipids in critical illness polyneuropathy. Intensive Care Med. 1998;24:87.
59. Topp R, Ditmyer M, King K, Doherty K, Hornyak J. The effect of bedrest and potential of prehabilitation on patients in the intensive care unit. AACN Clin Issues. 2002;13:263-276.
60. Booth F, Seider J. Early change in skeletal muscle protein synthesis after limb immobilization of rats. J Appl Physiol. 1979;47:974-977.
61. Fowles JR, Sale DG, MacDougal JD. Reduce strength after passive stretch of the human plantar flexors. J Appl Physiol. 2000;89:1179-1188.
62. Allen RA, Linderman JK, Roy RR, et al. Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighing. Am J Physiol. 1997;273:C579-C587.
63. Danon MJ, Carpenter S. Myopathy with thick filament myosin loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve. 1991;14:1131-1139.
64. Hasselgren PO, Fischer JE. The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of protein muscle breakdown during sepsis and other catabolic conditions. Ann Surg. 1997;225:307-316.
65. Kothman E, Baudouin SV. Mitochondrial dysfunction and critical illness myopathy. In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine. New York: Springer; 2006:79-87.
66. Fong Y. Cachectin TNF or Il-1a induces cachexia with redistribution of body proteins. Am J Physiol. 1989;256:659-665.
67. Callahan L, Methery D, Stofan D, DiMarco A, Supinski G. Free radical induced contractile protein dysfunction in endotoxin induced sepsis. Am J Respir Cell Mol Biol. 2001;24:210-217.
68. Rich MM, Teener JW, Raps EC, et al. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology. 1996;46:731-736.
69. Rich MM, Bird SJ, Raps EC, et al. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve. 1997;20:665-673.
70. Appel HJ. The muscle in the rehabilitation process. Orthopade. 1997;26:930-934.
71. Rich MM, Pinter MJ. Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol. 2001;50:26-33.
72. Rich MM, McGarvey ML, Teener JW, Frame LH. ECG changes during septic shock. Cardiologia. 2002;97:187-196.
73. Showalter CJ, Engel AG. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve. 1997;20:316-322.
74. Di Giovanni S, Mirabella M, D'Amico A, et al. Apoptotic features accompany acute quadriplegic myopathy. Neurology. 2000;55:854-858.
75. Leatherman JW, Fluegel WL, David WS, et al. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med. 1996;153:1686-1690.
76. Creditor MC. Hazards of hospitalization of the elderly. Ann Intern Med. 1993;118:219-223.
77. Stiller K. Physiotherapy in intensive care: towards an evidence-based practice. Chest. 2000;118:1801-1813.
78. Winkleman C, Higgins PA, Chen YJK. Activity in the chronically critically ill. Dimens Crit Care Nurse. 2005;24:281-290.
79. Kasper CE. Sarcolemmal disruption in reloaded atrophic skeletal muscle. J Appl Physiol. 1995;79:607-614.
80. Kasper CE, Maxwell IC, White TP. Alterations in muscle related to short-term impaired physical mobility. Res Nurs Health. 1996;19:133-142.
81. Bamman MM, Hunter GR, Stevens BR, Guilliams ME, Greenisen MC. Resistance exercise prevents plantar flexor deconditioning during bedrest. Med Sci Sports Exerc. 1997;29:1462-1468.
82. Inman CL, Warren GL, Hogan HA. Mechanical loading attenuates bone loss due to immobilization and calcium deficiency. J Appl Physiol. 1999;37:189-195.
83. Parsons HG, Mazier P, Withers G. Anaerobic exercise increases fat-free mass but not extracellular water during prolonged head down bedrest. Pflugers Arch. 2000;441(2/3, suppl):R73-R78.
84. Topp R, Ditmyer M, King K, Doherty K, Hornyak J. The effect of bedrest and potential of prehabilitation on patients in the intensive care unit. AACN Clin Issues. 2002;13:263-276.
85. Ditmyer MM, Topp R, Pifer M. Prehabilitation in preparation for orthopaedic surgery. Orthop Nurs. 2002;21(5):43-54.
86. Akima H, Kubo K, Kanchisa H, Suzuki Y, Gunji A, Fukunaga T. Leg press resistance training during 20 days of six degrees head down tilt bed rest prevents muscle deconditioning. Euro J Appl Physiol. 2000;80:30-38.
87. Keays SL, Bullock-Saxton J, Keays AC. Strength and function before and after anterior cruciate ligament reconstruction. Clin Orthopa Relat Res. 2000;373:174-183.